1.
Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiologica...
by Yusuf, Salim, Prof
The Lancet (British edition), 2011, Vol.378 (9798), p.1231-1243
2.
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
by Rothwell, Peter M, Prof
The Lancet (British edition), 2010, Vol.375 (9718), p.895-905
3.
Effect of Spironolactone on Blood Pressure in Subjects With Resistant Hypertension
by Chapman, Neil
Hypertension (Dallas, Tex. 1979), 2007-04, Vol.49 (4), p.839-845
4.
Prevalence of Resistant Hypertension in the United States, 2003–2008
by Persell, Stephen D
Hypertension (Dallas, Tex. 1979), 2011-06, Vol.57 (6), p.1076-1080
5.
Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients: Losartan Intervention for Endpoint Reduction in Hypertension Study
by Ibsen, Hans
Hypertension (Dallas, Tex. 1979), 2005-02, Vol.45 (2), p.198-202
6.
Left Atrial Size and Risk of Major Cardiovascular Events During Antihypertensive Treatment: Losartan Intervention for Endpoint Reduction in Hypertension Trial
by Gerdts, Eva
Hypertension (Dallas, Tex. 1979), 2007-02, Vol.49 (2), p.311-316
7.
Description of Antihypertensive Use in Patients With Resistant Hypertension Prescribed Four or More Agents
by Hanselin, Michele R
Hypertension (Dallas, Tex. 1979), 2011-12, Vol.58 (6), p.1008-1013
8.
Stroke Reduction in Hypertensive Adults With Cardiac Hypertrophy Randomized to Losartan Versus Atenolol: The Losartan Intervention For Endpoint Reduction in Hypertension Study
by Kizer, Jorge R
Hypertension (Dallas, Tex. 1979), 2005-01, Vol.45 (1), p.46-52
9.
Electrocardiographic Strain Pattern and Prediction of Cardiovascular Morbidity and Mortality in Hypertensive Patients
by Okin, Peter M
Hypertension (Dallas, Tex. 1979), 2004-07, Vol.44 (1), p.48-54
10.
Serum Uric Acid Is Associated With New-Onset Diabetes in Hypertensive Patients With Left Ventricular Hypertrophy: The LIFE Study
by Wiik, Benedicte P
American journal of hypertension, 2010-08, Vol.23 (8), p.845-851
11.
QRS Duration and QT Interval Predict Mortality in Hypertensive Patients With Left Ventricular Hypertrophy: The Losartan Intervention for Endpoint Reduction in Hypertension Study
by Oikarinen, Lasse
Hypertension (Dallas, Tex. 1979), 2004-05, Vol.43 (5), p.1029-1034
12.
Greater Regression of Electrocardiographic Left Ventricular Hypertrophy During Hydrochlorothiazide Therapy in Hypertensive Patients
by Okin, Peter M
American journal of hypertension, 2010-07, Vol.23 (7), p.786-793
13.
Prevalence and prognostic implications of electrocardiographic left ventricular hypertrophy in heart failure: evidence from the CHARM programme
by Hawkins, N M
Heart (British Cardiac Society), 2007-01, Vol.93 (1), p.59-64
14.
Mitral E Wave Deceleration Time to Peak E Velocity Ratio and Cardiovascular Outcome in Hypertensive Patients During Antihypertensive Treatment (from the LIFE Echo-Substudy)
by Chinali, Marcello, MD, PhD
The American journal of cardiology, 2009, Vol.104 (8), p.1098-1104
15.
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proo...
by Townsend, Raymond R
The Lancet (British edition), 2017-11-11, Vol.390 (10108), p.2160-2170
16.
Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data
by Sundström, Johan
The Lancet (British edition), 2014-08-16, Vol.384 (9943), p.591-598
17.
Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent...
by Muntner, Paul
Hypertension (Dallas, Tex. 1979), 2014-11, Vol.64 (5), p.1012-1021
18.
Impaired Capacity for Stimulated Fibrinolysis in Primary Hypertension Is Restored by Antihypertensive Therapy
by Ridderstråle, Wilhelm
Hypertension (Dallas, Tex. 1979), 2006-04, Vol.47 (4), p.686-691
19.
Butein in health and disease: A comprehensive review
by Padmavathi, Ganesan
Phytomedicine (Stuttgart), 2017-02-15, Vol.25, p.118-127
20.
Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis
by Xie, Xinfang, MD
The Lancet (British edition), 2016, Vol.387 (10017), p.435-443
